Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 15, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 10
- −1 vs. Q1 2022
- Portfolio value
- $117.6M
- −$54.5M (−31.7%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,336,909 | $33.3M | 28.3% | 00.0% | Unchanged | History |
| MEHCQChrome Holding Co. | CLASS A COM | 10,243,122 | $25.4M | 21.6% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,261,261 | $17.2M | 14.6% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 980,894 | $9.97M | 8.5% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 746,674 | $9.57M | 8.1% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 432,900 | $7.90M | 6.7% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 915,705 | $5.16M | 4.4% | 00.0% | Unchanged | History |
| FFBCFirst Financial Bancorp | COM | 173,576 | $3.37M | 2.9% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 747,550 | $3.35M | 2.8% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 802,963 | $2.41M | 2.0% | 00.0% | Unchanged | History |
Sold out since Q1 2022 (1)
Positions held at the end of Q1 2022 that are gone from this filing.